VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
LFMD
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
LFMDLifeMD, Inc.
$1.70$82M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksLFMDBalance Sheet

LifeMD, Inc. (LFMD) Balance Sheet

15Y historyFree accessUpdated daily

Total debt fell to $6.0M and the debt-to-equity ratio to 0.76, but cash declined from $36.8M to $25.1M over two quarters while the current ratio dropped to 0.90, suggesting liquidity pressure may be building.

Income StatementBalance SheetCash FlowRatios

LFMD Balance Sheet

Annual statement

LFMD Balance Sheet

LifeMD, Inc. (LFMD) balance sheet — 15-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11
Total Current Assets49.26M51.83M48.73M42.6M11.31M44.92M12.41M2.75M1.61M1.26M789.82K448.47K131.47K450.73K212K128.66K
Cash & Short-Term Investments21.92M36.79M35M33.15M3.96M41.33M9.18M1.11M180.09K141.38K182.56K232.98K75.5K155.06K98.93K33.5K
Cash Only21.92M36.79M35M33.15M3.96M41.33M9.18M1.11M180.09K141.38K182.56K232.98K75.5K155.06K98.93K33.5K
Short-Term Investments0000000000000000
Accounts Receivable13.25M9.31M8.22M5.28M2.83M980.05K997.76K97.45K99.05K128.19K446.99K154.44K14.97K209.47K49.69K36.36K
Days Sales Outstanding21.2117.514.1212.638.693.859.772.854.349.2631.1446.257.6594.5826.9217.84
Inventory10.35M2.77M2.8M2.76M3.7M1.62M1.26M950.06K1.02M707.16K160.27K61.05K41.01K86.19K63.38K58.8K
Days Inventory Outstanding59.2525.7642.4253.372.4132.7952.08137.32189.56173.9730.0689.9486.59173.53184.1588.96
Other Current Assets3.52M2.65M2.67M934.51K687.02K793.19K154.88K442.97K270.01K296.48K000000
Total Non-Current Assets17.02M18.58M23.73M15.88M14.35M5M990.26K699.08K1.01M00043.75K100.72K157.7K214.67K
Property, Plant & Equipment6.53M5.27M7.88M1.07M1.68M1.99M274.44K23.63K000043.75K100.72K157.7K214.67K
Fixed Asset Turnover31.85x36.84x26.96x142.41x70.75x46.76x135.89x527.77x----16.32x8.03x4.27x3.46x
Goodwill0000000000000000
Intangible Assets10.5M262.33K15.85M14.81M12.67M3.02M715.82K675.45K1.01M0000000
Long-Term Investments0000000000000000
Other Non-Current Assets013.05M000000000000-157.7K0
Total Assets66.29M70.41M72.46M58.48M25.67M49.92M13.4M3.45M2.62M1.26M789.82K448.47K175.22K551.45K369.69K343.33K
Asset Turnover2.83x2.76x2.93x2.61x4.64x1.86x2.78x3.62x3.18x4.00x6.63x2.72x4.08x1.47x1.82x2.17x
Asset Growth %-25.7%-2.83%23.9%127.85%-48.59%272.48%288.92%31.73%107%60.01%76.11%155.95%-68.23%49.16%7.68%-
Total Current Liabilities61.7M41.57M60.26M34.78M31.37M22.83M13.93M3.98M1.19M640.97K1.15M267.48K301.52K325.56K187.1K561.51K
Accounts Payable37.74M14.15M16.01M11.08M10.11M9.06M10.41M3M869K473.49K752.93K167.48K141.32K185.36K187.1K199.34K
Days Payables Outstanding282.18131.43242.78214.07197.61183.75428.72433.34161.08116.48141.22246.72298.42373.17543.63301.58
Short-Term Debt008.44M327.6K2.8M63.4K779.13K814.73K247.42K167.48K206.37K100K27.2K40.2K0262.17K
Deferred Revenue (Current)44.05M10.81M14.48M8.83M5.55M1.5M916.88K075.98K-473.49K0-167.48K-274.32K-40.2K00
Other Current Liabilities02.41M5.11M3M576.03K1.66M237.04K109.55K-869K-422.35K-560.68K-167.48K133K000
Current Ratio0.80x1.25x0.81x1.22x0.36x1.97x0.89x0.69x1.35x1.97x0.69x1.68x0.44x1.38x1.13x0.23x
Quick Ratio0.63x1.18x0.76x1.15x0.24x1.90x0.80x0.45x0.49x0.87x0.55x1.45x0.30x1.12x0.79x0.12x
Cash Conversion Cycle-201.71-88.16-186.24-148.14-116.51-147.11-366.88-293.1732.8266.74-80.01-110.54-204.17-105.06-332.56-194.78
Total Non-Current Liabilities5.16M5.68M16.25M18.13M1.6M1.28M292.32K599.98K604K00013.2K30.4K47.6K64.8K
Long-Term Debt009.89M17.93M000000000000
Capital Lease Obligations16.16M5.68M6.27M73.85K574.14K1.18M192.32K29.98K00000000
Deferred Tax Liabilities000000004K00013.2K30.4K47.6K64.8K
Other Non-Current Liabilities00100K131.25K1.02M100K100K570K600K0000000
Total Liabilities66.86M47.25M76.51M52.91M32.97M24.1M14.22M4.58M1.8M640.97K1.15M267.48K314.72K355.96K234.7K626.31K
Total Debt5.85M6.32M25.1M18.93M4.13M1.85M1.06M844.71K247.42K167.48K206.37K100K27.2K40.2K0262.17K
Net Debt-16.07M-30.46M-9.9M-14.21M168.52K-39.48M-8.11M-261.91K67.32K26.1K23.8K-132.98K-48.3K-114.86K-98.93K228.67K
Debt / Equity-10.10x0.27x-3.40x-0.07x--0.30x0.27x-0.55x-0.21x--
Debt / EBITDA-0.43x---------------
Net Debt / EBITDA1.18x---------------
Interest Coverage-6692.61x-6.48x-7.40x-5.71x-31.10x-19.31x-34.67x-3.80x-5.80x-12.72x-24.16x-3.60x-101.00x-83.33x-136.30x-23.46x
Total Equity-579.65K23.16M-4.05M5.57M-7.31M25.82M-821.76K-1.13M819.74K622.84K-361.73K180.99K-139.5K195.49K135K-282.98K
Equity Growth %6467.17%672.42%-172.68%176.19%-128.29%3241.91%27.23%-237.76%31.61%272.19%-299.86%229.74%-171.36%44.81%147.71%-
Book Value per Share-0.010.51-0.100.16-0.240.96-0.06-0.110.090.07-0.050.03-0.020.030.02-0.04
Total Shareholders' Equity-579.65K23.16M-5.49M3.51M-6.83M26.85M1.35M-988.18K897.7K881.92K-355.17K100.08K-139.5K195.49K135K-282.98K
Common Stock483.59K467.6K422.94K383.59K315.53K307.05K234.34K106.81K457.82K444.93K355.7K320.1K307.3K301.05K289.1K247.29K
Retained Earnings-256.34M-228.6M-236.25M-214.27M-190.56M-141.92M-80.15M-16.59M-12.14M-10.9M-9.69M-8.59M-8.52M-8.06M-7.8M-7.35M
Treasury Stock-163.7K-163.7K-163.7K-163.7K-163.7K-163.7K-163.7K-163.7K-163.7K-163.7K-87.05K0000-51.83K
Accumulated OCI00000000000-679.29K-635.54K000
Minority Interest001.44M2.06M-475.55K-1.03M-2.18M-141.06K-77.96K-259.08K-6.55K80.91K0000

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetMixed
Cash FlowDeteriorating
Top Statement Risk

Shrinking equity and cash erosion

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Equity Rebuilt From Deep Deficit

Based on LifeMD's reported figures, shareholders' equity swung from a deficit of $7.7M in 2024Q3 to $23.2M in 2025Q4 before falling back to $8.0M in 2026Q2, signaling that the balance sheet recovery has partly reversed.

The move into positive equity during late 2025 appears driven by the sharp reduction in total liabilities from $73.2M to $47.3M, likely reflecting debt repayment and a shrinking liability base rather than operating earnings. The subsequent decline in equity alongside a $10.6M fall in total assets from 2025Q4 to 2026Q2 suggests the improvement may not be durable. Investors should monitor whether asset contraction continues to outpace liability reduction.

Leverage Normalized but Liquidity Thinning

Per reported balance sheet data, total debt fell from $25.1M in early 2025 to $6.0M in 2026Q2, lowering the debt-to-equity ratio to 0.76, yet cash declined from $36.8M to $25.1M over two quarters.

The reduction in debt materially lowers refinancing risk, which is a constructive development for a company with thin equity. However, the pattern of retiring obligations while cash balances decline suggests the deleveraging was funded from the company's own reserves rather than from recurring cash generation. The quarter-to-quarter D/E swings from 0.27 to 0.76 indicate that headline leverage figures are sensitive to small equity changes and should be read with caution.

Current Ratio Slips Below Parity

According to reported financial statements, LifeMD's current ratio fell from 1.25 in 2025Q4 to 0.90 in 2026Q2, placing current liabilities above current assets for the first time in the displayed period.

A current ratio below 1.0 means short-term obligations exceed liquid resources, which warrants closer attention given that cash fell by roughly $11.7M over the same two quarters. Cash of $25.1M still provides a meaningful buffer against near-term obligations, but the trajectory implies that continued operating losses would erode this cushion. The business appears to depend on sustained cash preservation to maintain its current position.

Accumulated Deficit Dwarfs Equity Base

Based on LifeMD's reported figures, retained earnings stood at negative $246.1M in 2026Q2, roughly thirty times the $8.0M of total equity, reflecting a long history of cumulative losses.

The scale of the accumulated deficit indicates that the current positive equity is the product of paid-in capital rather than retained profits. Reported stock-based compensation of $2.1M to $4.2M per quarter continues to add to paid-in capital, which may dilute existing holders over time. Investors should weigh whether the equity base can absorb further losses without requiring additional capital raises.

Goodwill Collapse Obscures Asset Quality

As reported in the financial statements, goodwill fell from $16.7M in 2025Q2 to $198.5K in 2026Q2, a reduction that may reflect impairment and substantially reshapes the reported asset base.

A near-complete write-down of goodwill can make the remaining asset base appear cleaner, but it also signals that acquired value has been reassessed sharply lower. The reduction in total assets is therefore partly non-operational, which complicates comparisons of underlying performance. Whether the impairment reflects a broader reassessment of acquired businesses warrants further investigation through the filings.

LFMD — Frequently Asked Questions

Quick answers to the most common questions about buying LFMD stock.

What are the total assets of LifeMD, Inc. (LFMD)?

As of 2025, LifeMD, Inc. (LFMD) had total assets of $70.4M including $51.8M in current assets.

How much debt does LifeMD, Inc. (LFMD) have?

LifeMD, Inc. (LFMD) carries total debt of $6.3M, offset by $36.8M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of LifeMD, Inc.?

LifeMD, Inc. (LFMD) has total shareholders' equity (book value) of $23.2M ($0.51 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is LifeMD, Inc.'s current ratio and liquidity?

LifeMD, Inc. (LFMD) reported a current ratio of 1.25x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.